Tillomed is a european pharmaceutical company, specialising in the research, development, manufacture and marketing of speciality and generic medicines in the following therapeutic areas: oncology, analgesia, cardio-vascular, women’s health, anti-infectives, anti-epileptics, gastro-intestinal, genito-urinary, immunosuppressants, mental health and osteoporosis.